Inovedis

Eden Prairie, United States Founded: 2019 • Age: 7 yrs
Developer of surgical implants for tendon healing
Annual revenue $403,091 Latest available
Total funding $4.0M 1 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Inovedis

Inovedis is a company based in Eden Prairie (United States) founded in 2019 by Stefan Welte. Inovedis has raised $4 million across 1 funding round from investors including RENOLIT, High-Tech Gründerfonds and MBG. Inovedis offers products and services including SINEFIX Implant System. Inovedis operates in a competitive market with competitors including Miach Orthopaedics, RevBio, Dimension Inx, PolyNovo and Nanochon, among others.

  • Headquarter Eden Prairie, United States
  • Founders Stefan Welte
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Inovedis Gmbh
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $403.09 K (USD)
    19.31
    as on Mar 31, 2022
  • Net Profit
    $26.11 K (USD)
    -14.87
    as on Mar 31, 2022
  • EBITDA
    $31.2 K (USD)
    28.43
    as on Mar 31, 2022
  • Total Equity Funding
    $4 M (USD)

    in 1 rounds

  • Latest Funding Round
    $4 M (USD), Series A

    Oct 04, 2023

  • Investors
    RENOLIT

    & 3 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Inovedis

Inovedis offers a comprehensive portfolio of products and services, including SINEFIX Implant System.

Product name locked
Category locked
Primary

Device simplifies rotator cuff repair by improving fixation and reducing complications.

Funding Insights of Inovedis

Inovedis has successfully raised a total of $4M through 1 strategic funding round. The most recent funding activity was a Series A round of $4 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Inovedis

Inovedis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include RENOLIT, High-Tech Gründerfonds and MBG.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Locked Locked Locked
Venture capital firm focused on small and mid-sized companies
Locked Locked Locked
Start-up BW is supported as an initiative for entrepreneurship in Baden-Württemberg.
Locked Locked Locked
Premium access

Investor details for Inovedis

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Inovedis

Investments
Premium access

Investment portfolio details for Inovedis

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Inovedis

Premium access

Detailed financials for Inovedis

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Inovedis Comparisons

Inovedis Primary company
Description
Developer of surgical implants for tendon healing
Location
Eden Prairie, United States
Founded Year
2019
Annual Revenue
$403.09 K (USD)
Net Profit
$26.11 K (USD)
EBITDA
$31.2 K (USD)
Employees
Not available
Premium access

Peer comparison for Inovedis

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Inovedis

Inovedis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miach Orthopaedics, RevBio, Dimension Inx, PolyNovo and Nanochon, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Bio-engineered surgical implants for connective tissue repair are developed.
Locked Locked Locked
Synthetic adhesives for bone and dental repair are developed.
Locked Locked Locked
3D biomaterials are provided for regenerative medicine applications.
Locked Locked Locked
Developer of biodegradable temporising matrix for treating traumatic wounds
Locked Locked Locked
3D-printed implants are developed for treating joint injuries.
Locked Locked Locked
Gel4Med is focused on developing bioinspired medical solutions.
Premium access

Detailed competitors of Inovedis

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Inovedis

Premium access

Complete news archive for Inovedis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Inovedis

Inovedis was founded in 2019 and raised its 1st funding round 4 years after it was founded.

Inovedis is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.

Stefan Welte is the current CEO of Inovedis. They have also founded this company.

Inovedis is a funded company, having raised a total of $4M across 1 funding round to date.

Annual revenue of Inovedis is $403.09K as on Mar 31, 2022.

Inovedis was founded in 2019 and is headquartered in Eden Prairie, United States. Operations focus on the medical device sector, where surgical implants for tendon healing are developed. The SINEFIX Implant System is provided to support rotator cuff repair procedures. Patient outcomes are targeted for improvement through simplified surgical techniques. Leadership includes co-founders Stefan Welte and Lukas Floß.

Inovedis's top competitors include RevBio, Miach Orthopaedics and Nurami Medical.

Inovedis offers SINEFIX Implant System.

Inovedis has 4 investors. Key investors include RENOLIT, High-Tech Gründerfonds, MBG, and Start-up BW.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available